Physician

Parampreet Singh Ghuman, MD

According to 2025 Medicare claims, Parampreet Ghuman, MD (NPI: 1528228186) practices nephrology in the Mount Vernon-Anacortes, WA market, with the plurality of this provider's patient population coming from Skagit, WA. This provider's primary affiliated billing organization is C J KUAN MD INC PS (NPI: 1053592022; TIN: 912171951) and primary practice location at 98274-4035. Ghuman is affiliated with the CommonSpirit ACO I (ACO ID: A2164) and PSW ACO (ACO ID: A5323), participating under the MSSP model.

Ghuman's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 442 traditional Medicare patients, billed 1,342 HCPCS/CPT codes, and received $182,238 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 2,595 prescription claims across 393 beneficiaries totaling $218,402 in drug costs, led by Jardiance (Empagliflozin). DME data shows 332 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $240,172 to $182,238. Similarly, Part D prescription costs have moved from a higher plateau to a lower plateau, from $207,525 to $218,402. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $0 to $0.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	432	2,067	$240,172
2016	532	2,258	$270,580
2017	526	2,573	$293,053
2018	504	2,776	$323,218
2019	486	2,365	$309,532
2020	418	1,830	$237,974
2021	417	1,702	$255,105
2022	372	1,408	$217,186
2023	451	1,572	$211,818
2024	442	1,342	$182,238

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	179	1,460	$207,525
2016	340	2,586	$310,675
2017	359	3,595	$483,534
2018	389	4,288	$433,151
2019	378	4,392	$403,655
2020	350	3,432	$285,657
2021	337	2,981	$236,414
2022	326	2,328	$215,470
2023	365	2,371	$223,402
2024	393	2,595	$218,402

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	43	$1,709
2016	N/R	23	$879
2017	N/R	115	$7,544
2018	N/R	265	$13,141
2019	22	453	$21,359
2020	37	515	$22,876
2021	42	540	$19,411
2022	N/R	303	$8,405
2023	N/R	368	$6,624
2024	N/R	332	$5,206

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	58	58	$164
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	239	401	$131
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	47	69	$97
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	121	178	$90
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	61	133	$65

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Jardiance	Empagliflozin	74	3,780	$73,370
Lokelma	Sodium Zirconium Cyclosilicate	24	1,260	$31,211
Sevelamer Carbonate	Sevelamer Carbonate	64	2,873	$16,678
Potassium Citrate Er	Potassium Citrate	54	4,101	$12,467
Cinacalcet Hcl	Cinacalcet Hcl	85	6,450	$10,571

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7518	Mycophenolic acid, oral, 180 mg	N	N/R	53	$1,686
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	92	$1,417
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	60	$1,048
J7507	Tacrolimus, immediate release, oral, 1 mg	N	N/R	85	$1,026
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	N	N/R	42	$30

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Parampreet Singh Ghuman, MD?

Tedicare shows public-source Medicare data for Parampreet Singh Ghuman, MD (NPI 1528228186), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Parampreet Singh Ghuman, MD have ACO affiliation data?

Parampreet Singh Ghuman, MD is shown with ACO affiliation data for CommonSpirit ACO I (MSSP, ACO ID A2164) and PSW ACO (MSSP, ACO ID A5323).

What billing organization is linked to Parampreet Singh Ghuman, MD?

Parampreet Singh Ghuman, MD is linked to C J KUAN MD INC PS (billing NPI 1053592022) in the available physician profile data.

Does Parampreet Singh Ghuman, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.